Related Experiment Video

Updated: May 8, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance

Hoin Kang1, Chongtae Kim, Heejin Lee

  • 1Department of Biochemistry, College of Medicine, Catholic University of Korea, Seoul 137-701, Korea. kanghoin1@naver.com

International Journal of Molecular Sciences
|August 23, 2013
PubMed

Insights

Drug resistance in cancer treatment fails therapies. RNA binding proteins (RBPs) and microRNAs (miRNAs) regulate this resistance, offering potential new therapeutic strategies for overcoming cancer treatment failure.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Acquired drug resistance is a major cause of anti-cancer treatment failure.
  • Tumor genetic and epigenetic variations contribute to drug resistance.
  • Current cancer therapies face limitations in overcoming resistance.

Purpose of the Study:

  • To review the role of post-transcriptional regulators in drug resistance.
  • To explore the clinical implications of RNA binding proteins (RBPs) and microRNAs (miRNAs) in overcoming cancer resistance.
  • To understand the molecular mechanisms of drug resistance acquisition.

Main Methods:

  • Literature review of studies on drug resistance mechanisms.
  • Analysis of the role of RNA binding proteins (RBPs) and microRNAs (miRNAs).
  • Examination of ribonucleoprotein complexes in cancer drug resistance.

Main Results:

  • Drug resistance is regulated by post-transcriptional mechanisms involving RBPs and miRNAs.
  • These regulators affect mRNA stability and translation of key cancer-related factors.
  • Ribonucleoprotein complexes play critical roles in the development of drug resistance.

Conclusions:

  • Understanding RBPs and miRNAs is crucial for developing strategies against cancer drug resistance.
  • Targeting ribonucleoprotein complexes offers potential clinical applications for improving cancer therapy.
  • Further research into these regulators may lead to overcoming treatment failure in cancer.

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...